Evaluation of a Targeted Drug‐Eluting Intravascular Nanotherapy to Prevent Neointimal Hyperplasia in an Atherosclerotic Rat Model-Reference-Cited by-同舟云学术

Evaluation of a Targeted Drug‐Eluting Intravascular Nanotherapy to Prevent Neointimal Hyperplasia in an Atherosclerotic Rat Model

Published:2021-05-03 Issue:7 Volume:1 Page:2000093
ISSN:2699-9307
Container-title:Advanced NanoBiomed Research
language:en
Short-container-title:Adv NanoBio Res

Author:

Newton Emily R.¹,Gillis David C.¹,Sun Kui¹,Dandurand Brooke R.¹,Siletzky Robin¹,Biswas Suvendu²,Karver Mark R.²,Tsihlis Nick D.¹,Stupp Samuel I.²³⁴,Kibbe Melina R.¹⁵^ORCID

Affiliation:

1. Department of Surgery Center for Nanotechnology in Drug Delivery University of North Carolina at Chapel Hill Burnett Womack Suite 4041, 101 Manning Drive Chapel Hill NC 27599-7050 USA

2. Simpson Querrey Institute Northwestern University Chicago IL 60611 USA

3. Department of Medicine Northwestern University Chicago IL 60611 USA

4. Departments of Chemistry Materials Science and Engineering Biomedical Engineering Northwestern University Evanston IL 60208 USA

5. Department of Biomedical Engineering University of North Carolina at Chapel Hill Chapel Hill NC 27599 USA

Funder

National Institutes of Health

National Science Foundation

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/anbr.202000093

Reference30 articles.

1. Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association

2. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis

3. Formation and Transformation of Neointima after Drug-eluting Stent Implantation: Insights from Optical Coherence Tomographic Studies

4. Pathology of Drug-Eluting Stents in Humans

5. U. S. FDA FDA Executive Summary: Paclitaxel-Coated Drug Coated Balloon and Drug-Eluting Stent Late Mortality Panel https://www.fda.gov/media/127698/download(accessed: January 2020).